Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2016 Nov 29

PMID 27893329

Citations 11

Authors

Jeffrey S Weber

Laura A Levit

Peter C Adamson

Suanna S Bruinooge

Howard A Burris 3rd

Michael A Carducci

Adam P Dicker

Mithat Gonen

Stephen M Keefe

Michael A Postow

Michael A Thompson

David M Waterhouse

Susan L Weiner

Lynn M Schuchter

Affiliations

Soon will be listed here.

Citing Articles

Decision-making and autonomy among participants in early-phase cancer immunotherapy trials: a qualitative study.

Avery J, Bell J, Baryolay K, Rodin G, Nissim R, Balneaves L BMC Cancer. 2024; 24(1):373.

PMID: 38528488 PMC: 10962144. DOI: 10.1186/s12885-024-12119-7.

Rural cancer disparities from Oklahoma cancer and vital records registries 2016-2020.

Campbell J, Sambo A, Hunsucker L, Pharr S, Doescher M Cancer Epidemiol. 2023; 88:102512.

PMID: 38113701 PMC: 10872521. DOI: 10.1016/j.canep.2023.102512.

Expanding access to early phase trials: the CATCH-UP.2020 experience.

Baranda J, Diaz F, Rubinstein L, Shields A, Dayyani F, Mehta A JNCI Cancer Spectr. 2022; 7(1).

PMID: 36525371 PMC: 9825762. DOI: 10.1093/jncics/pkac087.

The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care Improvement.

Grisafi D, Ceschi A, Avalos Clerici V, Scaglione F Curr Ther Res Clin Exp. 2021; 94:100628.

PMID: 34306268 PMC: 8296076. DOI: 10.1016/j.curtheres.2021.100628.

Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution.

Menon S, Davies A, Frentzas S, Hawkins C, Segelov E, Day D Cancer Rep (Hoboken). 2021; 5(2):e1465.

PMID: 34245134 PMC: 8842700. DOI: 10.1002/cnr2.1465.

References

Kimmelman J . Is Participation in Cancer Phase I Trials Really Therapeutic?. J Clin Oncol. 2016; 35(2):135-138. PMC: 5321666. DOI: 10.1200/JCO.2016.67.9902. View

. American Society of Clinical Oncology policy statement: oversight of clinical research. J Clin Oncol. 2003; 21(12):2377-86. DOI: 10.1200/JCO.2003.04.026. View

Topalian S, Sznol M, Mcdermott D, Kluger H, Carvajal R, Sharfman W . Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol. 2014; 32(10):1020-30. PMC: 4811023. DOI: 10.1200/JCO.2013.53.0105. View

Jansen L, Mahadevan D, Appelbaum P, Klein W, Weinstein N, Mori M . The Impact of Unrealistic Optimism on Informed Consent in Early-Phase Oncology Trials. IRB. 2018; 38(5):1-7. View

Hay M, Thomas D, Craighead J, Economides C, Rosenthal J . Clinical development success rates for investigational drugs. Nat Biotechnol. 2014; 32(1):40-51. DOI: 10.1038/nbt.2786. View